Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
The Nasdaq Biotechnology Index maintains a gain of over 1.1%, after previously rising more than 1.4%.

The Nasdaq Biotechnology Index maintains a gain of over 1.1%, after previously rising more than 1.4%.

华尔街见闻华尔街见闻2026/05/04 15:50
Show original
Constituent stocks Replimune rose by 21.40%, Cabaletta Bio increased by 20.24%, Aura Biosciences gained 16.83%, Mirum Pharmaceuticals went up 13.63%, and Zenas Biopharma also climbed 9.99%. Jyong Biotech closed down 4.00%, Gossamer Bio fell 5.35%, Twist Bioscience dropped 5.36%, and First Tracks Biotherapeutics also declined by 7.64%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Mortgage rates return to 7%, pending home sales in the US fall to nearly a twelve-year low

According to Freddie Mac data, the 30-year fixed mortgage rate has risen to 7.4%, the highest level in nearly three years. Data from real estate brokerage Redfin shows that the volume of existing home pending sales in September fell 4% month-on-month, marking the largest single-month drop in over three years and hitting the lowest level since 2014. Nearly one-fifth of sellers have reduced prices, and the home purchase contract cancellation rate has reached a record high of 14.5%. Inventory levels have risen to the highest since March 2020, but high financing costs continue to constrain transactions.

华尔街见闻•2026/10/12 20:41
Mortgage rates return to 7%, pending home sales in the US fall to nearly a twelve-year low

GLD ETF Falls 0.6%

Dow Jones•2026/10/12 20:35